For example, inhibiting the miR-130/301 family resulted in the reversal of established PAH [91], as did administration of tacrolimus (FK506) or the endogenous elastase inhibitor elafin, which reportedly increased apelin expression through enhancing BMPR-II signalling [94,95]. This evidence concerns the gene APLN and pulmonary arterial hypertension.